MENU

Fox Chase Cancer Center Proudly Supports Pancreatic Cancer Action Network (PanCAN) PurpleStride Philadelphia 2018

October 2, 2018

PHILADELPHIA (October 2, 2018) – Fox Chase Cancer Center, a designated National Pancreatic Foundation Center, will again field a team of faculty, staff, patients, and friends to raise funds at the Pancreatic Cancer Action Network (PanCAN) PurpleStride Philadelphia. The event will be held on Saturday, November 3 at Memorial Hall in Fairmount Park. Registration opens at 6:00 am and the 5K run/walk starts at 8:00 am.

Edna Cukierman, PhD, co-leader of the Marvin & Concetta Greenberg Pancreatic Cancer Institute at Fox Chase, will lead the Fox Chase team.

Over the past decade, PanCAN has raised more than $87 million via its community events to improve pancreatic cancer outcomes through advanced science and clinical care.

Please visit foxchase.org/PurpleStride2018 for more information or to join or support the Fox Chase Cancer Center team.

       

The Hospital of Fox Chase Cancer Center and its affiliates (collectively “Fox Chase Cancer Center”), a member of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship and community outreach. 
For more information, call 1-888-FOX CHASE or (1-888-369-2427).

Connect with Fox Chase